![](/img/cover-not-exists.png)
2.3 Cardiovascular (CV) Safety of Linagliptin in Patients with Type 2 Diabetes (T2D): A Pooled Comprehensive Analysis of Prospectively Adjudicated CV Events in Phase 3 Studies (376-OR)
Johansen, Odd Erik, Neubacher, Dietmar, Seck, Thomas, Patel, Sanjay, Woerle, Hans J.Volume:
11
Journal:
Nederlands Tijdschrift voor Diabetologie
DOI:
10.1007/s12467-013-0037-3
Date:
September, 2013
File:
PDF, 102 KB
2013